166 related articles for article (PubMed ID: 18508458)
1. Tremorolytic effects of adenosine A2A antagonists: implications for parkinsonism.
Salamone JD; Betz AJ; Ishiwari K; Felsted J; Madson L; Mirante B; Clark K; Font L; Korbey S; Sager TN; Hockemeyer J; Muller CE
Front Biosci; 2008 May; 13():3594-605. PubMed ID: 18508458
[TBL] [Abstract][Full Text] [Related]
2. Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide.
Betz AJ; Vontell R; Valenta J; Worden L; Sink KS; Font L; Correa M; Sager TN; Salamone JD
Neuroscience; 2009 Sep; 163(1):97-108. PubMed ID: 19467297
[TBL] [Abstract][Full Text] [Related]
3. The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism.
Correa M; Wisniecki A; Betz A; Dobson DR; O'Neill MF; O'Neill MJ; Salamone JD
Behav Brain Res; 2004 Jan; 148(1-2):47-54. PubMed ID: 14684247
[TBL] [Abstract][Full Text] [Related]
4. Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism.
Collins-Praino LE; Paul NE; Ledgard F; Podurgiel SJ; Kovner R; Baqi Y; Müller CE; Senatus PB; Salamone JD
Eur J Neurosci; 2013 Jul; 38(1):2183-91. PubMed ID: 23600953
[TBL] [Abstract][Full Text] [Related]
5. Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX.
Collins LE; Galtieri DJ; Brennum LT; Sager TN; Hockemeyer J; Müller CE; Hinman JR; Chrobak JJ; Salamone JD
Pharmacol Biochem Behav; 2010 Feb; 94(4):561-9. PubMed ID: 19958787
[TBL] [Abstract][Full Text] [Related]
6. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.
Podurgiel SJ; Nunes EJ; Yohn SE; Barber J; Thompson A; Milligan M; Lee CA; López-Cruz L; Pardo M; Valverde O; Lendent C; Baqi Y; Müller CE; Correa M; Salamone JD
Neuroscience; 2013 Oct; 250():507-19. PubMed ID: 23867769
[TBL] [Abstract][Full Text] [Related]
7. Induction of oral tremor in mice by the acetylcholinesterase inhibitor galantamine: Reversal with adenosine A2A antagonism.
Podurgiel SJ; Spencer T; Kovner R; Baqi Y; Müller CE; Correa M; Salamone JD
Pharmacol Biochem Behav; 2016 Jan; 140():62-7. PubMed ID: 26459156
[TBL] [Abstract][Full Text] [Related]
8. Blockade of adenosine A
Kosmowska B; Ossowska K; Wardas J
Behav Brain Res; 2022 Jan; 417():113585. PubMed ID: 34536428
[TBL] [Abstract][Full Text] [Related]
9. Conditional neural knockout of the adenosine A(2A) receptor and pharmacological A(2A) antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor.
Salamone JD; Collins-Praino LE; Pardo M; Podurgiel SJ; Baqi Y; Müller CE; Schwarzschild MA; Correa M
Eur Neuropsychopharmacol; 2013 Aug; 23(8):972-7. PubMed ID: 22947264
[TBL] [Abstract][Full Text] [Related]
10. The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade.
Collins LE; Sager TN; Sams AG; Pennarola A; Port RG; Shahriari M; Salamone JD
Pharmacol Biochem Behav; 2012 Jan; 100(3):498-505. PubMed ID: 22037410
[TBL] [Abstract][Full Text] [Related]
11. Dopamine/adenosine interactions related to locomotion and tremor in animal models: possible relevance to parkinsonism.
Salamone JD; Ishiwari K; Betz AJ; Farrar AM; Mingote SM; Font L; Hockemeyer J; Müller CE; Correa M
Parkinsonism Relat Disord; 2008; 14 Suppl 2(Suppl 2):S130-4. PubMed ID: 18585081
[TBL] [Abstract][Full Text] [Related]
12. Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor.
Podurgiel S; Collins-Praino LE; Yohn S; Randall PA; Roach A; Lobianco C; Salamone JD
Pharmacol Biochem Behav; 2013 Apr; 105():105-11. PubMed ID: 23360954
[TBL] [Abstract][Full Text] [Related]
13. Injections of the selective adenosine A2A antagonist MSX-3 into the nucleus accumbens core attenuate the locomotor suppression induced by haloperidol in rats.
Ishiwari K; Madson LJ; Farrar AM; Mingote SM; Valenta JP; DiGianvittorio MD; Frank LE; Correa M; Hockemeyer J; Müller C; Salamone JD
Behav Brain Res; 2007 Mar; 178(2):190-9. PubMed ID: 17223207
[TBL] [Abstract][Full Text] [Related]
14. The non-selective adenosine antagonist theophylline reverses the effects of dopamine antagonism on tremor, motor activity and effort-based decision-making.
Pardo M; Paul NE; Collins-Praino LE; Salamone JD; Correa M
Pharmacol Biochem Behav; 2020 Nov; 198():173035. PubMed ID: 32910928
[TBL] [Abstract][Full Text] [Related]
15. Tremulous jaw movements in rats: a model of parkinsonian tremor.
Salamone JD; Mayorga AJ; Trevitt JT; Cousins MS; Conlan A; Nawab A
Prog Neurobiol; 1998 Dec; 56(6):591-611. PubMed ID: 9871939
[TBL] [Abstract][Full Text] [Related]
16. Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats.
Ishiwari K; Betz A; Weber S; Felsted J; Salamone JD
Pharmacol Biochem Behav; 2005 Feb; 80(2):351-62. PubMed ID: 15680188
[TBL] [Abstract][Full Text] [Related]
17. Motor effects of GABA(A) antagonism in globus pallidus: studies of locomotion and tremulous jaw movements in rats.
Wisniecki A; Correa M; Arizzi MN; Ishiwari K; Salamone JD
Psychopharmacology (Berl); 2003 Nov; 170(2):140-9. PubMed ID: 12827348
[TBL] [Abstract][Full Text] [Related]
18. The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates.
Varty GB; Hodgson RA; Pond AJ; Grzelak ME; Parker EM; Hunter JC
Psychopharmacology (Berl); 2008 Oct; 200(3):393-401. PubMed ID: 18594798
[TBL] [Abstract][Full Text] [Related]
19. The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors.
Betz AJ; McLaughlin PJ; Burgos M; Weber SM; Salamone JD
Psychopharmacology (Berl); 2007 Oct; 194(3):347-59. PubMed ID: 17594079
[TBL] [Abstract][Full Text] [Related]
20. Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP.
Shiozaki S; Ichikawa S; Nakamura J; Kitamura S; Yamada K; Kuwana Y
Psychopharmacology (Berl); 1999 Nov; 147(1):90-5. PubMed ID: 10591873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
